EMBCライブシグナル | Getagraph.comで利益を最大化

買う 107879 min ago

@ $14.75

発行日: 15 2月 2024 @ 03:48

リターン: -28.81%

前回のシグナル: 2月 15 - 01:25

前回のシグナル: 売る

リターン: 0.20 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:47):

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes...

Stats
本日の出来高	87 584.00
平均出来高	432 548
時価総額	604.58M
EPS	$0.590 ( 2024-02-09 )
次の収益日	( $0.430 ) 2024-05-10
Last Dividend	$0.150 ( 2023-12-01 )
Next Dividend	$0 ( N/A )
P/E	10.94
ATR14	$0.0140 (0.13%)

Insider Trading

Date	Person	Action	Amount	type
2022-04-01	Reidy Christopher R	Sell	0	Common Stock
2022-04-01	Melcher David F	Sell	0	Common Stock
2024-04-04	Kurdikar Devdatt	Sell	4 535	Common Stock
2024-02-11	Kurdikar Devdatt	Sell	17 165	Common Stock
2024-02-12	Melcher David F	Buy	2 000	Common Stock

INSIDER POWER
77.58
Last 100 transactions
Buy: 2 135 787 \| Sell: 79 609

ボリューム相関

長: -0.25 (neutral)

短: -0.14 (neutral)

Signal:(56.469) Neutral

Embecta Corp. 相関

10 最も正の相関
RMRM	0.938
ONEM	0.898
KPRX	0.884
GAINL	0.88
BLTE	0.879
QTEK	0.868
EMKR	0.862
CYRN	0.86
ONCR	0.859
TLGT	0.856

10 最も負の相関
AMPH	-0.904
UFPT	-0.885
ABEO	-0.875
NVDA	-0.875
PETQ	-0.874
SDGR	-0.873
ALSK	-0.871
PCYG	-0.87
HGBL	-0.868
QQQM	-0.868

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Embecta Corp. 相関 - 通貨/商品

0.46
( neutral )

0.43
( neutral )

0.00
( neutral )

0.31
( neutral )

-0.40
( neutral )

-0.64
( weak negative )

Embecta Corp. 財務諸表

Annual	2023
収益:	$1.12B
総利益:	$749.90M (66.91 %)
EPS:	$1.230

FY	2023
収益:	$1.12B
総利益:	$749.90M (66.91 %)
EPS:	$1.230

FY	2022
収益:	$1.13B
総利益:	$774.90M (68.61 %)
EPS:	$3.92

FY	2021
収益:	$1.17B
総利益:	$800.00M (68.67 %)
EPS:	$7.28

Financial Reports:

No articles found.

Embecta Corp. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.150 (N/A)	$0.150 (N/A)	$0.150 (N/A)	$0.150 (N/A)	$0.150 (N/A)	$0.150 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Embecta Corp. Dividend Information - Dividend Junior

Dividend Sustainability Score: 4.97 - low (65.10%) | Divividend Growth Potential Score: 0.974 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.150	2022-08-25
Last Dividend	$0.150	2023-12-01
Next Dividend	$0	N/A
Payout Date	2023-12-15
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$0.900	--
Avg. Dividend % Per Year	0.90%	--
Score	2.81	--
Div. Sustainability Score	4.97
Div.Growth Potential Score	0.974
Div. Directional Score	2.97	--

Next Divdend (Est)
(2024-07-01)

$0.152 Estimate 36.00 %

Dividend Stability

0.72 Good

Dividend Score

2.81

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2022	$0.300	0.64%
2023	$0.600	2.37%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0493	1.500	9.01	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0454	1.200	8.49	10.00	[0 - 0.3]
returnOnEquityTTM	-0.0681	1.500	-1.868	-2.80	[0.1 - 1]
payoutRatioTTM	0.778	-1.000	2.22	-2.22	[0 - 1]
currentRatioTTM	2.20	0.800	3.99	3.19	[1 - 3]
quickRatioTTM	1.547	0.800	5.61	4.49	[0.8 - 2.5]
cashRatioTTM	0.915	1.500	6.03	9.05	[0.2 - 2]
debtRatioTTM	1.344	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	1.633	1.000	-0.506	-0.506	[3 - 30]
operatingCashFlowPerShareTTM	-0.101	2.00	-0.0336	-0.0673	[0 - 30]
freeCashFlowPerShareTTM	-0.527	2.00	-0.264	-0.527	[0 - 20]
debtEquityRatioTTM	-2.06	-1.500	-8.25	10.00	[0 - 2.5]
grossProfitMarginTTM	0.666	1.000	2.24	2.24	[0.2 - 0.8]
operatingProfitMarginTTM	0.159	1.000	8.82	8.82	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.00354	1.000	-1.131	-1.131	[0.2 - 2]
assetTurnoverTTM	0.922	0.800	7.19	5.75	[0.5 - 2]
Total Score				4.97

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	10.72	1.000	9.02	0	[1 - 100]
returnOnEquityTTM	-0.0681	2.50	-1.201	-2.80	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.527	2.00	-0.176	-0.527	[0 - 30]
dividendYielPercentageTTM	5.82	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.101	2.00	-0.0336	-0.0673	[0 - 30]
payoutRatioTTM	0.778	1.500	2.22	-2.22	[0 - 1]
pegRatioTTM	-0.156	1.500	-4.37	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.00517	1.000	-2.63	0	[0.1 - 0.5]
Total Score				0.974

Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.